Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to ...

A new report from Novotech reveals the OV market is expanding at pace, with a compounding annual growth rate of 14.2% between 2019 and 2024. More than 95% of ongoing trials involving oncolytic viruses ...

Oncolytic Viruses companies are Targovax, Genelux, Imugene, EpicentRx, Replimune, Candel Therapeutics, DNAtrix, CG Oncology, Amgen, Daiichi Sankyo, etc ALBANY, NY ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will participate in the ...

Scientists in China have developed a modified virus that causes cancer cells to make sugars normally found in pigs, causing ...

As our knowledge of science and the human body expands, so too do doctors have more tools at hand when treating cancer. One ...

Newcastle disease virus (NDV) is an avian paramyxovirus ... Other proteins such as H-Ras and Rac1 have been shown to mediate oncolytic specificity in certain systems. The NDV genome allows ...

Merck & Co’s $394 million acquisition of Viralytics has stoked interest in oncolytic viruses, a class of drugs that have been in the shadow of the checkpoint inhibitors and CAR-T therapies that ...

Oncolytic virus therapy is not a new discovery, but it may now be positioned as the next major breakthrough in cancer treatment following the success of checkpoint inhibitors in immunotherapy.

Explore the role of preclinical MRI in studying neurological diseases, with a focus on advanced cellular and molecular ...

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...